LENVIMA caps 10 mg 30 pce

7680655120020 CH-65512 L01EX08 07.16.1.

Reimbursement limitations:

LENVIMA.01

Carcinome thyroïdien différencié (DTC)
Carcinome thyroïdien différencié, localement avancé ou métastatique, réfractaire à l'iode radioactif …

LENVIMA caps 10 mg 30 pce
LENVIMA caps 10 mg 30 pce
LENVIMA caps 10 mg 30 pce
1 / 3
google

Details

Product number
6551202
CPT
-
Packaging group
30
Unit
Kapsel(n)
Composition
lenvatinibum 10 mg ut lenvatinibi mesilas, calcii carbonas, mannitolum, cellulosum microcristallinum, hydroxypropylcellulosum, hydroxypropylcellulosum substitutum humile, talcum, Kapselhülle: hypromellosum, E 171, E 172 (flavum), E 172 (rubrum), Drucktinte: lacca, E 172 (nigrum), kalii hydroxidum, propylenglycolum, pro capsula.

Articles (1)

Lenvima 10 mg, Hartkapseln
Kapseln
30
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
22/10/2025
Patient information leaflet
Français
22/10/2025
Patient information leaflet
Italien
22/10/2025
Professional SmPC
Allemand
22/10/2025
Professional SmPC
Français
22/10/2025
Professional SmPC
Italien
22/10/2025

Detailed composition

Substance Quantity Type Category
(N/A)
10.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance FTODK
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)

Reimbursement information

Public price
CHF 1583.35
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/10/2015

Authorization holder

Eisai Pharma AG

8050 Zürich

Authorization information

Swissmedic authorization number
65512
Drug name
Lenvima, Hartkapseln
Galenic form
KAHA
ATC Code
L01EX08
Authorization status
Z
Dispensation category
A
First authorization
19/08/2015
Authorization expiration date
31/12/9999
IT number
07.16.1.
Domain
Human medicine
Field of application
Onkologikum

Packaging details

Description (FR)
LENVIMA caps 10 mg 30 pce
Description (DE)
LENVIMA Kaps 10 mg 30 Stk
Market launch
19/08/2015
Narcotic (BTM)
No

Other packaging sizes

LENVIMA caps 4 mg 30 pce
30 KAP
View